In both LN229 and T98G cell lines, CYBRD1 overexpression promoted cell viability (Figure 3(b)), migratory ability as revealed by wound healing assay (Figure 3(c)), and invasive ability as revealed by Transwell assay (Figure 3(d)); on the contrary, CYBRD1 silencing attenuated glioma cell aggressiveness (Figures 3(b)–3(d)). The gene discussed is CYBRD1; the disease is glioma.